SWOBY vs MRK: Which Stock is Better?

Side-by-side comparison of Swedish Orphan Biovitrum AB (publ) and Merck & Co Inc in 2026

Comparison Updated:

SWOBY

Swedish Orphan Biovitrum AB (publ)

$19.63

MRK

Merck & Co Inc

$115.46

Key Metrics Comparison

MetricSWOBYMRKWinner
Market Cap$14.20B$291.50BMRK
P/E Ratio280.3916.22MRK
EPS (TTM)$0.07$7.27MRK
Revenue Growth0.1%0.1%SWOBY
Gross Margin78.2%77.2%SWOBY

Analyze SWOBY

Full quant analysis

Analyze MRK

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SWOBY or MRK a better investment?

Comparing SWOBY and MRK: Swedish Orphan Biovitrum AB (publ) has a market cap of $14.20B while Merck & Co Inc has $291.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SWOBY and MRK?

SWOBY (Swedish Orphan Biovitrum AB (publ)) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SWOBY or MRK?

Based on P/E ratios, MRK trades at a lower multiple (16.2x vs 280.4x).

Which is growing faster: SWOBY or MRK?

SWOBY has higher revenue growth at 0.1% vs 0.1% for MRK.

Which company is more profitable: SWOBY or MRK?

Swedish Orphan Biovitrum AB (publ) (SWOBY) has higher gross margins at 78.2% compared to 77.2% for MRK.

Which is the larger company: SWOBY or MRK?

Merck & Co Inc (MRK) is larger with a market cap of $291.50B compared to $14.20B for SWOBY.

Should I buy SWOBY or MRK in 2026?

Both SWOBY and MRK have investment merit. SWOBY trades at $19.63 while MRK trades at $115.46. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SWOBY and MRK stock?

Key differences: Market Cap ($14.20B vs $291.50B), P/E Ratio (280.4x vs 16.2x), Revenue Growth (0.1% vs 0.1%), Gross Margin (78.2% vs 77.2%).

Popular Stock Comparisons